Latest stab in the wrinkle wars
Could this be the 21st century version of the cola wars? The botulinum toxin type A injectable known as Dysport (manufactured by Medicis) was FDA-approved for cosmetic use today. It’s the first wrinkle relaxer to be OK’d since Allergan’s Botox was given the green light in 2002.
Now that Dysport (which was test-named Reloxin and has been used in the UK since 1991) will soon be available in doctors’ offices, we’re curious to see which one will come out on top. The two formulas employ the same mechanism and are, say physicians, nearly indistinguishable. Medicis and Allergan already make competing hyaluronic acid wrinkle fillers (Restylane and Juvederm, respectively). Can we expect a price war between the two wrinkle busters? Devotees of the creaseless look can only hope.
Read our October 2008 story about Medicis and its feng shui-loving CEO, Jonah Shacknai, here.
Photo by Kyle Ericksen